Bristol-Myers Squibb Says AI Is Already Speeding Up Drug Research — And It's Measuring The Impact
Bristol-Myers beats Q3 2026 estimates with $13.07B in revenue and raises full-year sales guidance driven by newer drug growth.
Share
Why It Matters
Bristol-Myers made more money than expected this quarter. Their newer medicines are selling well, which shows their AI tools may be helping them find drugs faster.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.